CompoAtlas

NMN300MG Plus Resveratrol & PQQ

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
trans-Resvératrol

Source : Resvératrol

50 mg
Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo-

Source : Pyrroloquinoline quinone disodium salt

20 mg

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps (to) maintain/support the body's ability to metabolize nutrients. Helps in energy metabolism/(and) tissue formation. NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health. NMN is a NAD+ precursor which is a factor in normal growth and development. NMN is a NAD+ precursor which is an important cofactor in energy metabolism. Supports biological functions which play a key role in the maintenance of good health. (Provides) An antioxidant.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Vitaleyoumi Wellness Inc.
NPN or DIN-HM
80143609
Status
Active licence
Licence date
21 August 2025
Revision date
Not provided
Form
Capsule, dur
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80143609

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “NMN300MG Plus Resveratrol & PQQ”, https://compoatlas.com/en/supplements/canada/80143609-nmn300mg-plus-resveratrol-pqq, updated 21 August 2025.

Enter to analyse, Shift+Enter for a new line